Latest Breaking News On - Centre for technology - Page 13 : comparemela.com

 E-Mail IMAGE: Upon collection after the delivery of a baby, cord blood is processed to extract stem cells and to prepare it for long-term cryopreservation view more  Credit: Cordlife Group Limited SINGAPORE, 11 May 2021 - Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore s first private cord blood bank, Cordlife Group Limited (Cordlife), to test a novel technology that expands the number of blood-forming stem cells from stored umbilical cord blood (UCB) in a first-in-man study in Singapore. This is the first time a home-grown UCB cell therapy is being tested on humans. The technology has the potential to increase treatment options for patients suffering from blood cancers or blood-related conditions.

Chris laingWilliam hwangCordlife group limitedCell therapy centreDepartment of haematologyDepartment of haematology at singaporeDevelopment jointcteNational cancer centre singaporeStem cell biology programmeAcademic medical centreCentre for technologyBlood cancer centreMedical centreProfessor william hwangStem cell biologyProf hwang